SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Vascular and Endovascular Surgery
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mureebe, L.
Right arrow Articles by Silver, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mureebe, L.
Right arrow Articles by Silver, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Heparin-Induced Thrombocytopenia: Pathophysiology and Management

Leila Mureebe, MD

Donald Silver, MD

Division of Vascular Surgery, University of Missouri Health Sciences Center, Columbia, MO

Immune-mediated heparin-induced thrombocytopenia (HIT) is a well-defined syndrome. Clinical criteria (thrombocytopenia, resistance to heparin anticoagulation, or thromboses during heparin therapy) are defined, and serologic diagnostic tests are available. Earlier recognition of HIT syndrome has allowed for significant advances in therapy, leading to marked reductions in morbidity and mortality from HIT syndrome. This review addresses the epidemiology, pathobiology, and management of HIT syndrome

Vascular and Endovascular Surgery, Vol. 36, No. 3, 163-170 (2002)
DOI: 10.1177/153857440203600302


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
V. Gupta, R. Tanvir, A. Garg, S.B. Gaikwad, and N.K. Mishra
Heparin-Induced Thrombocytopenia in a Case of Endovascular Aneurysm Coiling
AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 155 - 158.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A complication of hip surgery
Postgrad. Med. J., May 1, 2003; 79(931): 301 - 301.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Sundaram, Y. Qi, Z. Shriver, D. Liu, G. Zhao, G. Venkataraman, R. Langer, and R. Sasisekharan
Rational design of low-molecular weight heparins with improved invivo activity
PNAS, January 21, 2003; 100(2): 651 - 656.
[Abstract] [Full Text] [PDF]



Advertisement